
NBE-Therapeutics is a privately owned Swiss, Basel-based Biotech company that was founded in 2012 with the vision to develop next-generation ADCs improving treatment options for cancer patients. The company is financially backed by the Boehringer Ingelheim Venture Fund and additional private investors.
It is NBE Therapeutics vision to become a leader in antibody-based drug development by developing its own portfolio of drugs until demonstration of a clinical proof-of-concept in man.
Developer of antibody based drugs. The company engages in providing antibody drug conjugates for the treatment of cancer.

Avise NBE Therapeutics que você está Interessado em trabalhar para a companhia, ao mesmo tempo matenha a sua anônimidade. Comparably dará NBE Therapeutics a oportunidade de te contratar quando uma vaga com a sua cara aparecer!
Enviar a eles uma mensagem para valiar a cultura da companhia